Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005;65(3):341-84.
doi: 10.2165/00003495-200565030-00004.

Second-generation antihistamines: actions and efficacy in the management of allergic disorders

Affiliations
Review

Second-generation antihistamines: actions and efficacy in the management of allergic disorders

Larry K Golightly et al. Drugs. 2005.

Abstract

Antihistamines are useful medications for the treatment of a variety of allergic disorders. Second-generation antihistamines avidly and selectively bind to peripheral histamine H1 receptors and, consequently, provide gratifying relief of histamine-mediated symptoms in a majority of atopic patients. This tight receptor specificity additionally leads to few effects on other neuronal or hormonal systems, with the result that adverse effects associated with these medications, with the exception of noticeable sedation in about 10% of cetirizine-treated patients, resemble those of placebo overall. Similarly, serious adverse drug reactions and interactions are uncommon with these medicines. Therapeutic interchange to one of the available second-generation antihistamines is a reasonable approach to limiting an institutional formulary, and adoption of such a policy has proven capable of creating substantial cost savings. Differences in overall efficacy and safety between available second-generation antihistamines, when administered in equivalent dosages, are not large. However, among the antihistamines presently available, fexofenadine may offer the best overall balance of effectiveness and safety, and this agent is an appropriate selection for initial or switch therapy for most patients with mild or moderate allergic symptoms. Cetirizine is the most potent antihistamine available and has been subjected to more clinical study than any other. This agent is appropriate for patients proven unresponsive to other antihistamines and for those with the most severe symptoms who might benefit from antihistamine treatment of the highest potency that can be dose-titrated up to maximal intensity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Allergy. 1997 Jul;52(7):752-4 - PubMed
    1. Ophthalmology. 2004 Jul;111(7):1275-9 - PubMed
    1. Clin Ther. 2003 May;25(5):1518-38 - PubMed
    1. Acta Derm Venereol. 1990;70(2):151-3 - PubMed
    1. J Burn Care Rehabil. 2001 Jul-Aug;22(4):263-8 - PubMed

LinkOut - more resources